Clinical outcomes after initial treatment of methicillin-resistant <em>Staphylococcus aureus</em> infections

Abstract

In this observational study reflecting real-world conditions, vancomycin was associated with higher 30-day mortality and incidence of kidney dysfunction than other anti-MRSA agents. The significance of the differences observed among antimicrobials other than vancomycin is uncertain.